Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Evaluate the Efficacy and Safety of R-CHOP-MTX±Zanubrutinib in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients with Central Nervous System Involvement, and Explore the Efficacy Indicators of CSF-ctDNA.
Epistemonikos ID: b2a2d20523a1970bd08f9868f84f3c3c1af20413
First added on: Oct 01, 2024